Corpus 1,273 assessed · 1,174 scored · 643 reproduced ≥75 · 169 flagged ·∅ 74.1/100

Publications 2 Datasets 392.5k Experiments 4.7k

Explore

Filters: partial ✕ John Radcliffe Hospital ✕ 1 ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders. PMID 41734765	Cell Stem Cell	2026	65	L1 65/100
Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation. PMID 34795257	Nat Commun	2021	67	L1 67/100

comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders.

PMID 41734765 · Cell Stem Cell · 2026

L1 65/100

Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.

PMID 34795257 · Nat Commun · 2021

L1 67/100